Background: Anal cancer has become one of the most common non-AIDS-defined tumors among Human Immunodeficiency Virus-positive (HIV+) individuals, and a rise in its incidence among HIV+ Men who have Sex with Men (MSM) has been shown, despite the introduction of Highly Active Anti-Retroviral Therapy (HAART). Human Papillomavirus (HPV) infections are highly prevalent among HIV+ MSM and recent studies have shown high rates of HPV-associated anal intraepithelial neoplasia (AIN) and anal cancer among this population.
Background
HPV are well known for their association with cervical cancer [1] , and have also been shown to play a role in the pathogenesis of distinct squamous cell cancers, including anal [2, 3] , penile [4, 5] , oropharyngeal [6, 7] vulvar, and conjunctival [8] cancers. Concurrent infection with HIV may facilitate or accelerate the pathological consequences of HPV infections. Persistent HPV infections are very frequent among HIV+ MSM [9] . Anal HPV infections, which contribute to the development of anal warts and anal cancer, are very common among MSM, especially HIV+ individuals [10] and HPV-associated ano-genital malignancies occur particularly in patients with Acquired Immunodeficiency Syndrome (AIDS) [11] . HIV+ MSM are at 37-fold greater risk of invasive anal cancer. Likewise, the incidence of anal cancer and anal intraepithelial neoplasia (AIN), the potential precursor lesion of squamous cell carcinoma of the anus is very high among HIV+ MSM [12] and a definite increasing trend in the incidence of anal cancer has been shown despite the use of Highly Active Antiretroviral Therapy (HAART) [13] .
Infections with HPV represent the most common sexually transmitted disease worldwide. HPV is a double-stranded DNA virus, and 160 different types of HPV officially described have been found at mucosal or cutaneous sites, each with a specific tissue tropism. At least 30 of them have been identified with high predilection for the ano-genital tract. Specific types, such as 6 and 11, are classified as low-risk (LR) types because they have been found to be associated only with benign lesions. In contrast, high-risk (HR) types, including most notably 16 and 18, have been found to be associated with both low-and high-grade anal squamous intraepithelial lesions (ASIL) as well as the majority of cervical and anal cancers [14, 15] .
Risk factors for the presence of anal HPV include the presence of anal warts and a history of receptive anal intercourse, HIV infection, and a low CD4 cell count [16] . In a Spanish cohort HR and LR HPV types were very prevalent in the anus of HIV+ MSM (83% and 72.7%, respectively), with type 16 being the most common one. Concurrent infection with several HPV types was also common among HIV+ MSM (58.5%) [17] . In addition, HIV+ men have higher rates of HPV anal infection and higher levels of HPV type 16 than HIV-men [16, 18] .
In a recent study in immunocompetent heterosexual men, the incidence of overall ano-genital HPV infections was 24.8% [19] .
The anal and cervical epithelia possess similar embryonic origins. Histologically, columnar epithelium with a transition zone (with increased metaplastic activity) and a more differentiated squamous epithelium are observed. The anal and cervical epithelia are infected by the same types of HPV, producing similar manifestations that range from condyloma to squamous intraepithelial lesions (SILs) and cancer.
The fact that multiple concurrent infections with HPV constitute an associated morbidity among patients infected with HIV has only recently been recognized [20] .
In [21] .
In this study, we determined the prevalence of HPV types infecting the anal canal of HIV+ MSM and characterized the type 16 variants. In addition, we characterized the HPV types associated with HPV type 16 in the anal canals of these patients.
Methods

Samples
We analyzed 324 anal exudates from HIV+ MSM patients attending the HIV Clinic at the Instituto Nacional de Ciencias Médicas y Nutrición "Salvador Zubirán" (INCMNSZ) in Mexico City. Patients over 18 years old, who presented to care between August and December 2008, were invited to participate. Samples were obtained with a cytobrush and inserted into a tube collector containing PreservCyt. The study was approved by the Ethics Committees of INCMNSZ SSA, and the Instituto Nacional de Cancerología, SSA. Written informed consent was obtained from all of the participants.
Data collection
Socio-demographic, clinical and sexual behavior information was collected using a self-applied written questionnaire, with 
Statistical analyzes
The statistical analyzes were performed by using the Kruskall-wallis test for continuous variables and chisquare test and Fisher-exact test were done to compare proportions of categorical variables.
Results
A total of 324 MSM patients attending the HIV/AIDS Clinic at the INCMNSZ between August and December 2008 were invited and agreed to participate in this study. The majority was young adults (39.1, SD = 9.4) years old, educated and economically active (79.2% had more than 9 years of education, and 77.1% were employed at entry).
The mean duration of HIV infection since diagnosis was 83 (SD = 66.4) months. Approximately 58.4% of the participants had received a diagnosis of AIDS at some point during the course of their HIV disease. Three hundred two (92.4%) of 324 patients were being treated with HAART; 85.1% of the patients exhibited a T lymphocyte CD4 count above 200 cells/μl (mean = 442 cells/ ml), and 75% exhibited <400 copies/ml of HIV-1 RNA. A significant association was found between presence of HPV and age. HPV-patients were older than those that were HPV+ ( Table 1) .
The total prevalence of HPV in the anal canal of this population was very high (86%; 279/324). Of the HPV+ samples, 27.5% were positive for type 16 (77/279), 8.6% for type 18 (24/279), 36% for both types (101/279) and 64% for other HPV types (178/279). Finally, only 45 samples were found to be HPV-(13.6%) ( Table 2) . In order to try to characterize HPV type 16 variants present in this population, and due to limited resources, 39 HPV16+ samples were subjected to further analysis by sequencing the LCR and E6 regions. Among this subpopulation, three variants of HPV type 16 were identified. The most prevalent variants (70%) were the European variants (E), followed by Asian American (AA) variants (22.5%) and African (Af) variants (2.5%). Within the European variants, we identified 7 different subclasses: E-P in 11 samples, E-m in 2 samples, E-G131G in 2 samples, E-A176T in one sample, E-A176G in 6 samples, E-A178T in 3 samples, and E-C188G in 5 samples. Concerning the Asian American variants, we identified 2 subclasses: AAa in 6 samples and AAc in 3 samples. Finally, an Af variant was identified in one sample. All of these results are summarized in Figure 1 . The fact that the majority of type HPV type 16 variants present in this population were of the European lineage could suggest a reduced risk to develop anal lesions and cancer for individuals carrying them, as compared to individual that carry Asian-American variants, has been shown for cervical cancer [22] .
In addition, we analyzed which other types of HPV were present in this sub-population of 39 samples of HPV type 16+ individuals. The most frequent co-infecting HPV genotypes were 6, 11, 44 and 70 among the low-risk types; 16, 18, 52, 26, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, and 59 among the high-risk types; and 66 (probable high risk), 69/71 and 74, which are currently considered indeterminate risk (see Figure 2) .
The distribution of the number of different HPV types in this sub-population is shown in Figure 3 . Two peaks, one of 11 individuals with 5 different viral types and the other with 3 individuals with 13 different types were seen. We observed that only 5% of the 39 HPV type 16+ samples analyzed were singly or double infected, whereas 95% of the type 16+ samples exhibited multiple HPV infections. Among multiply infected samples, 5% (2/39) had 3 viral types, 13% (5/39) had 4 viral types, 28.5% (11/39) had 5 viral types, 10.25% (4/39) had 6 viral types, and 7.7% (3/39) had 7, 8 or 13 different viral types. A detailed analysis of the different types of HPV present in this population is shown in Figure 4 .
We performed a statistical analysis to compare clinical variables among HPV type 16/18+ and HPV-patients and found that age, viral suppression and time since diagnosis were significantly different among them. HPV-patients were older, have more HIV viral suppression and more time since diagnosis than HPV16/18+ patients (see Table 3 ). Further studies comparing the prevalence of HPV in the oral cavity among these patients will be performed with a follow-up that could address the prevalence of HPV and anal lesions among this cohort of HIV+ MSM.
Discussion and conclusions
HPV has been extensively studied for its role in cervical cancer development, but its association with anal cancer is less well defined. This study was conducted among HIV+ MSM attending a specialty medical center in Mexico City. We observed a high prevalence of HPV infections in the anal region, confirming previous reports [17, 18] . HR HPV types were most prevalent among a subgroup of HPV16+ patients, similar to what has been shown in previous studies of patients in Spain, Denmark and Sweden [17, 24] . The fact that HPV16 was the most prevalent is in agreement with previous reports. To our knowledge this is the first report on the presence of variants of HPV16 among HIV+ MSM.HPV16 was found in 23.8% of our patients, similar to what has been reported previously [25] . It is known that infection with HIV increases the risk of acquisition of HPV and suggests that persistence of HPV may also be increased [24] .
The high prevalence of anal HPV, particularly type 16 could considerably increase the possibility of developing anal cancer among this population. Our results suggest that the early detection and treatment of lesions in the anal epithelium of these individuals may prevent anal cancer, one of the few non-AIDS-defining malignancies. Priority should be given to the identification and treatment of anal lesions in MSM with HIV/AIDS [26] .
In Mexico, few data on this type of cancer, and even fewer with respect to the HIV+ population, have been obtained. Here, we describe the prevalence of different HPV types co-infecting individuals with HPV type 16, and we identify the type 16 variants in the anal canal of a population of HIV+ MSM. 
